Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of geriatric comanagement with reduction in adverse surgical outcomes among patients 75 or older with cancer with prolonged hospital stay
    Meeting Abstract

    Shahrokni, A.; Kim, S. J.; Alexander, K.; Sun, S. W.; McMillan, S.; Downey, R. J.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Factors associated with referral for perioperative geriatric comanagement (GERI-CO) program in 12,398 older adults with cancer
    Meeting Abstract

    Shahrokni, A.; Alexander, K.; Kim, S. J.; McMillan, S.; Downey, R. J.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Morphologic and molecular analysis of early-onset gastroesophageal adenocarcinomas
    Meeting Abstract

    Setia, N.; Wang, C.; Lager, A.; Maron, S. B.; Peterson, B.; Arndt, N.; Misdraji, J.; Ma, C.; Kupfer, S.; Hart, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomized controlled trials
    Meeting Abstract

    Ronellenfitsch, U.; Jensen, K.; Seide, S.; Kieser, M.; Schwarzbach, M.; Slanger, T. E.; Burmeister, B.; Kelsen, D. P.; Niedzwiecki, D.; Piessen, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/II study of GB1275, a first-in-class oral CD11b modulator, alone, and combined with pembrolizumab in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (KEYNOTE-A36)
    Meeting Abstract

    Rasco, D. W.; Bendell, J. C.; Wang-Gillam, A.; Park, W.; O'Reilly, E. M.; Zhou, L.; Galkin, A.; Carter, L. L.; Nickle, D.; Li, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Concordance between independent and investigator assessment of disease-free survival (DFS) in the APACT trial
    Meeting Abstract

    Reni, M.; Riess, H.; O'Reilly, E. M.; Reeves, J. A.; Chiorean, E.; George, T. J.; Scheithauer, W.; Pascal, A.; Lerch, M.; Brenner, W. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region
    Meeting Abstract

    Reni, M.; Riess, H.; O'Reilly, E. M.; Park, J. O.; Hatoum, H.; Saez, B. L.; Salminen, T.; Oettle, H.; Lopez, R.; Dowden, S. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in hepatopancreaticobiliary (HPB) cancers
    Meeting Abstract

    Park, W.; Sokol, E.; Chen, J.; Yu, K. H.; Khalil, D.; Harding, J. J.; El Dika, I. H.; Riaz, N.; Abou-Alfa, G. K.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Therapeutic vulnerabilities among KRAS G12C mutant (mut) advanced cancers based on co-alteration (co-alt) patterns
    Meeting Abstract

    Nusrat, M.; Roszik, J.; Holla, V.; Cai, T.; Hong, M.; Coker, O.; Johnson, B.; Ahnert, J. R.; Janku, F.; Kopetz, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Peritoneal mesotheliomas characterized by less cell-cycle alterations and more TRAF7 alterations than malignant pleural mesotheliomas
    Meeting Abstract

    Offin, M.; Egger, J. V.; Cercek, A.; Nash, G. M.; Ladanyi, M.; Zauderer, M. G.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save